Bram van Dijck has extensive international experience in Life Sciences (Pharma, MedTech, Biotech) and Healthcare of which 25 years holding senior management positions in various companies. During his corporate career he had commercial roles (Sales & Marketing) and leadership roles as a Country Manager, European and Global Head in Pharma, Biotech and Biosimilars (e.g. Abbott, Knoll-BASF Pharma, Organon now MSD, Teva Pharmaceuticals, Hospira). In addition, he has co-founded a human vaccine company early 2000. Since 2013, he has run his consultancy and interim management company. He joined Cerba Research as CEO of the Netherlands business unit in November 2023. Bram holds an MBA from INSEAD (Fontainebleau, FR) and has studied economics and business administration.